Skip to main content

Table 2 Key patient meta-data and derived cell line properties (adapted from Q-Cell database [35])

From: Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas

Cell line

Patient age (years)

Patient Survival (Days)

RB pathway LOF

Cell line doubling time (hours)

XG median survival (days)

BAH1

75

94

Yes

79.5 ± 3.3

210 ± 8

FPW1

68

242

Yes

48.1 ± 4.7

196 ± 4

HW1

54

89

Yes

55.8 ± 2.7

174 ± 14

JK2

75

178

Yes

94.2 ± 4.5

147 ± 9

MMK1

80

334

Yes

52.4 ± 3.3

157 ± 15

MN1

84

36

Yes

44.9 ± 1.0

258 ± 20

PB1

57

39

Yes

79.4 ± 6.3

71 ± 1

RKI1

57

Alive (7 years)

No

72.9 ± 5.3

248 ± 6

RN1

56

243

Yes

37.5 ± 1.9

81 ± 2

SB2b

48

420

Yes

108.7 ± 6.9

120 ± 3.3

SJH1

72

45

Yes

67.3 ± 4.7

148 ± 4

WK1

77

121

Yes

46.2 ± 1.0

150 ± 2

  1. Metadata for patient age and survival post-diagnosis along with retinoblastoma status, doubling time for the derived cell lines and median survival of mice carrying orthotopic tumours. RB pathway LOF Loss of function in one or more steps in the retinoblastoma tumour suppressor pathway. XG median survival Median survival for mice with orthotopic xenografts